GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD)

CUSIP: M47238122

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / SHS NEW
Total 13F shares
396,731
Share change
+224,275
Total reported value
$112,946
Price per share
$0.28
Number of holders
11
Value change
+$62,648
Number of buys
3
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP M47238122?
CUSIP M47238122 identifies GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD) as of Q2 2024

As of 30 Jun 2024, GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 396,731 shares. The largest 10 holders included Walleye Capital LLC, CVI Holdings, LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES, LLC, UBS Group AG, WELLS FARGO & COMPANY/MN, Federation des caisses Desjardins du Quebec, OSAIC HOLDINGS, INC., and Allworth Financial LP. This page lists 11 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.